Today the share price of India’s leading pharma company Cipla Limited fell almost 3.5%. Cipla promoters Yusuf Hamied and Mustafa Hamied sold their 2.5% stake through a block deal.
Cipla told the exchanges that the promoters of the company, which is still in its eighties, are selling their stake due to personal and philanthropy reasons.
Now the promoter group holds a 34.23% stake in Cipla and the company said that the promoter has no plans to sell a further stake in the near future.
Cipla has given almost 9.5% returns in the last one year and the share price of the company has increased by around 56% in the last 5 years.
| 52 Week High | 1,005.00 |
| 52 Week Low | 738.10 |
| Sector PE | 35.80 |
| Face Value | 2 |
| Dividend Yield | 0.54 |
| Mkt Cap (Rs. Cr.) | 74,375 |
| Book Value Per Share | 229.84 |
Read Also: BSE stock rise 8% on announcing 2:1 bonus share issue, Q3 net up 86% at Rs 58.6 cr
| Net Profit 2021 (Rs. Cr.) | 2,401 |
| Debt to equity (2021) | 0.08 |
| Revenue 2021 (Rs. Cr.) | 19,159 |
| EPS | 29.82 |
| ROE | 13.12 |
| Dividend/Share (INR) (Mar 2021) | 5.00 |
| Promoters holding | 34.23% |
Read Also: India bans drone imports to boost domestic manufacturing, Zen Technologies stock 5% up
Read Also: Power Grid declared interim dividend of Rs 5.5 per share
This article is only for education purpose and the author has his own views and research, so if you invest in these stocks then do it at your own risk and do the research yourself before investing.
Read Also: PB Fintech stock down 8%, Founders to sell 2.4% stake in a block deal worth $140 million
Read Also: Nifty and Sensex down 1.7% on high US inflation, Fed’s James Bullard supports Rate hikes
Read Also: Definition and Current Repo Rate and Reverse Repo Rate